Drugs / MNI-815
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02531360 | May 2015 → Jul 2016 | Alzheimer disease, corticobasal syndrome, frontotemporal dementia, progressive supranuclear palsy | Molecular NeuroImaging | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNI-815 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02531360 ↗ |
| Modality | Diagnostic / imaging agent | “a PET radioligand for imaging Tau” NCT02531360 ↗ |